Global /India /Healthcare /Drug Manufacturers - General /BAJAJHCARE
chevron_leftBack
Bajaj HealthCare Ltd. logo

Bajaj HealthCare Ltd.

BAJAJHCARE
NSE: BAJAJHCARE Delayed
321.75INR -0.7%
3.41 USD
As of 25 June 2026, Bajaj HealthCare Ltd. has a market cap of $107.82M USD, ranking #24983 globally and #1512 in India. It ranks #2235 in the Healthcare sector, and #811 in the Drug Manufacturers - General industry.
Global Rank
24983
Country Rank
1512
Sector Rank
2235
Industry Rank
811
Key Stats
Market Cap
$107.82MUSD
10.22B INR
Enterprise Value
$132.09MUSD
12.46B INR
Revenue (TTM)
$64.64MUSD
6.12B INR
EBITDA (TTM)
$9.57MUSD
902.24M INR
Net Income (TTM)
$5.26MUSD
497.95M INR
EBITDA Margin
15%
Profit Margin
8.1%
PE Ratio
20.5
PS Ratio
1.7
PB Ratio
2.1
EV/EBITDA
13.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
918
Founded
1993
Website
bajajhealth.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.7% -1.4% 7.8% -5.6% -28% -44%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
BAJAJHCARE
Bajaj Healthcare Ltd
ISIN: INE411U01027
Shares Out.:
33.663M1 Shares Float: 2.612M2
TV:
SA:
YF:
GF:
BA:
MS:
321.75 INR
Bombay Stock Exchange
MIC: XBOM
539872 (BAJAJHCARE)
Bajaj Healthcare Ltd
ISIN: INE411U01027
TV:
SA:
YF:
GF:
BA:
MS:
323.45 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bajaj HealthCare Ltd.

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, phlebotropic drug, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.04B
4.27T INR
42K%
39.1
DIVISLAB
$18.31B
1.73T INR
17K%
70.0
$15.11B
1.43T INR
14K%
63.0
$11.69B
1.11T INR
11K%
19.6
MANKIND
$9.83B
931.67B INR
9K%
52.2
ZYDUSLIFE
$9.67B
916.53B INR
9K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
706K%
38.1
JNJ
$547.28B
507K%
26.4
ABBV
$360.63B
334K%
97.4
$316.37B
256.25B CHF
293K%
19.9
AZN
$284.33B
215.59B GBP
264K%
27.6
MRK
$274.03B
254K%
15.1
chevron_leftBack